Found: 47
Select item for more details and to access through your institution.
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
- Published in:
- Endocrine Reviews, 2024, v. 45, n. 3, p. 351, doi. 10.1210/endrev/bnad035
- By:
- Publication type:
- Article
Approach to the Patient: Insulinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 4, p. 1109, doi. 10.1210/clinem/dgad641
- By:
- Publication type:
- Article
Use and perceived utility of [<sup>18</sup>F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 1, p. 1, doi. 10.1111/jne.13359
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 8, p. 1, doi. 10.1111/jne.13318
- By:
- Publication type:
- Article
Epigenetic regulation of SST<sub>2</sub> expression in small intestinal neuroendocrine tumors.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1184436
- By:
- Publication type:
- Article
Fluorescence-guided surgery using methylene blue to improve identification of metastatic small intestinal neuroendocrine tumours.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 5, p. 541, doi. 10.1093/bjs/znad043
- By:
- Publication type:
- Article
Efficacy and safety of peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 4, p. 1195, doi. 10.1007/s00259-022-06044-9
- By:
- Publication type:
- Article
Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 40, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE in Neuroendocrine Tumor Patients.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5792, doi. 10.3390/cancers14235792
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3199, doi. 10.1210/clinem/dgac574
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Induction therapy with <sup>177</sup>Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3203, doi. 10.1007/s00259-022-05734-8
- By:
- Publication type:
- Article
Effect of epigenetic treatment on SST<sub>2</sub> expression in neuroendocrine tumour patients.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.957
- By:
- Publication type:
- Article
Molecular Imaging of Neuroendocrine Neoplasms.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 7, p. e2662, doi. 10.1210/clinem/dgac207
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 7, p. 1, doi. 10.1111/jne.13146
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with <sup>177</sup>LuDOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Comparison of [<sup>18</sup>F]DOPA and [<sup>68</sup>Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
- Published in:
- European Journal of Hybrid Imaging, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41824-022-00133-6
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e1969, doi. 10.1210/clinem/dgac001
- By:
- Publication type:
- Article
Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
- Published in:
- Prostate, 2022, v. 82, n. 5, p. 505, doi. 10.1002/pros.24297
- By:
- Publication type:
- Article
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13060
- By:
- Publication type:
- Article
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00880-4
- By:
- Publication type:
- Article
New Directions in Imaging Neuroendocrine Neoplasms.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01139-2
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2021, v. 22, n. 3, p. 581, doi. 10.1007/s11154-020-09552-x
- By:
- Publication type:
- Article
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 443, doi. 10.3390/cancers13030443
- By:
- Publication type:
- Article
Should everolimus be stopped after radiological progression in metastatic insulinoma? A "pro" point of view.
- Published in:
- 2021
- By:
- Publication type:
- Letter
COVID‐19‐associated immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e61, doi. 10.1111/bjh.16850
- By:
- Publication type:
- Article
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.
- Published in:
- Endocrine Reviews, 2020, v. 41, n. 2, p. 371, doi. 10.1210/endrev/bnz004
- By:
- Publication type:
- Article
Turning Up the Heat: Endoscopic Ablation of Pancreatic Neuroendocrine Neoplasms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using <sup>177</sup>Lu-DOTATATE.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 1, p. 45, doi. 10.1530/EJE-18-0901
- By:
- Publication type:
- Article
Letter to the Editor: "The Inflammation-Based Index Can Predict Response and Improve Patient Selection in NETs Treated With PRRT: A Pilot Study".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Symptomatic and Radiological Response to <sup>177</sup>Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 4, p. 1336, doi. 10.1210/jc.2018-01991
- By:
- Publication type:
- Article
Total and high‐affinity corticosteroid‐binding globulin depletion in septic shock is associated with mortality.
- Published in:
- Clinical Endocrinology, 2019, v. 90, n. 1, p. 232, doi. 10.1111/cen.13844
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
What's new on the HPA axis?
- Published in:
- Intensive Care Medicine, 2015, v. 41, n. 8, p. 1477, doi. 10.1007/s00134-015-3771-8
- By:
- Publication type:
- Article
Expression and Gene Variation Studies Deny Association of Human HSD3B1 Gene With Aldosterone Production or Blood Pressure.
- Published in:
- American Journal of Hypertension, 2015, v. 28, n. 1, p. 113, doi. 10.1093/ajh/hpu103
- By:
- Publication type:
- Article
Inhibin Alpha-Subunit (<i>INHA)</i> Expression in Adrenocortical Cancer Is Linked to Genetic and Epigenetic <i>INHA</i> Promoter Variation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104944
- By:
- Publication type:
- Article
Blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 6, p. 757, doi. 10.1111/bjh.12666
- By:
- Publication type:
- Article
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
- Published in:
- Prostate, 2013, v. 73, n. 15, p. 1636, doi. 10.1002/pros.22655
- By:
- Publication type:
- Article
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
- Published in:
- Orphanet Journal of Rare Diseases, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1750-1172-8-142
- By:
- Publication type:
- Article
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2013, v. 167, n. 1, p. 67, doi. 10.1530/EJE-12-0594
- By:
- Publication type:
- Article
Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2012, v. 13, n. 3, p. 360, doi. 10.1177/1470320312438792
- By:
- Publication type:
- Article
Renin and prorenin have no direct effect on aldosterone synthesis in the human adrenocortical cell lines H295R and HAC15.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Serum inhibin pro-&agr;C is a tumor marker for adrenocortical carcinomas.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 2, p. 281, doi. 10.1530/EJE-11-0693
- By:
- Publication type:
- Article